SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014242
Filing Date
2023-08-09
Accepted
2023-08-09 16:02:57
Documents
100
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20230630x10q.htm   iXBRL 10-Q 2086639
2 EX-31.1 irwd-20230630xex31d1.htm EX-31.1 16578
3 EX-31.2 irwd-20230630xex31d2.htm EX-31.2 16637
4 EX-32.1 irwd-20230630xex32d1.htm EX-32.1 7975
5 EX-32.2 irwd-20230630xex32d2.htm EX-32.2 8410
  Complete submission text file 0001558370-23-014242.txt   9914118

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20230630.xsd EX-101.SCH 85267
7 EX-101.CAL irwd-20230630_cal.xml EX-101.CAL 81111
8 EX-101.DEF irwd-20230630_def.xml EX-101.DEF 351054
9 EX-101.LAB irwd-20230630_lab.xml EX-101.LAB 613250
10 EX-101.PRE irwd-20230630_pre.xml EX-101.PRE 554991
94 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20230630x10q_htm.xml XML 1744740
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 231155009
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences